New blood test can detect Parkinson's disease before symptoms appear, offering hope for early intervention and better patient outcomes

Researchers have developed a simple and affordable blood test capable of identifying Parkinson's disease before symptoms appear by analyzing transfer RNA fragments in blood. The test, which costs about 80 pounds, provides an accurate and non-invasive diagnosis, with a score of 0.86, superior to current clinical tests. The breakthrough could revolutionize early diagnosis, paving the way for early treatments. Experts emphasize the need for further studies to validate the test.